Business
Directorate Change
Directorate Change.
About this update from Hvivo Plc
[{"type":"text","content":"\n\nhVIVO plc\n(\"hVIVO\", the \"Company\" or the \"Group\")\n \nDirectorate Change\n \nhVIVO plc (AIM: HVO), a full-service Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, announces that the Company has received notice of resignation from Tracey James as Non-Executive Director of the Board with immediate effect. The Company can confirm that Ms James' decision to resign from the Board is unrelated to the Company's financial performance or outlook. The Company's trading update for H1 2025 will be issued on 22 July 2025 as previously announced.\n \nThe Nominations Committee has commenced a process to appoint a new independent Non-Executive Director and the Company will announce the results of this process in due course.\n \nSeparately, the Nominations Committee is progressing well in its process to appoint a new independent Non-Executive Chair, a further announcement will be made in due course.\n \nFor further information please contact:\n \n\n\n\n\nhVIVO plc\n\n\n+44 (0)20 7756 1300\n\n\n\n\nYamin 'Mo' Khan, Chief Executive Officer\nStephen Pinkerton, Chief Financial Officer\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCavendish Capital Markets Limited (Nominated Adviser and Joint Broker)\n\n\n+44 (0)20 7220 0500\n\n\n\n\nGeoff Nash, Callum Davidson\nTrisyia Jamaludin, Harriet Ward\nNigel Birks - Life Science Specialist Sales\nLouise Talbot - Sales\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPeel Hunt LLP (Joint Broker)\n\n\n+44 (0)20 7418 8900\n\n\n\n\nJames Steel, Dr Christopher Golden\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nDavy (Joint Broker)\n\n\n+353 (0) 1 679 6363\n\n\n\n\nAnthony Farrell, Niall Gilchrist\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWalbrook PR (Financial PR & IR)\nPaul McManus / Alice Woodings \nLianne Applegarth\n\n\n+44 (0)20 7933 8780 or [email protected]\n+44 (0)7980 541 893 / +44 (0)7407 804 654\n+44 (0)7584 391 303\n\n\n\n\n\n\n\n\n\n\n\n \nThe information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (\"MAR\") EU no.596/2014. Upon the publication of this announcement via Regulatory Information Service (\"RIS\"), this inside information is now considered to be in the public domain. \n \n\n \nNotes to Editors\n \nhVIVO plc (Ticker: HVO) is ...